Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value

PLoS Medicine

Volumn 10, Issue 5, 2013, Pages

  Marisa, Laetitia ^a   de Reyniès, Aurélien ^a   Duval, Alex ^b,c   Selves, Janick ^d   Gaub, Marie Pierre ^e,f   Vescovo, Laure ^a   Etienne Grimaldi, Marie Christine ^g   Schiappa, Renaud ^a   Guenot, Dominique ^e   Ayadi, Mira ^a   Kirzin, Sylvain ^d   Chazal, Maurice ^h   Fléjou, Jean François ^b,c,i   Benchimol, Daniel ^j   Berger, Anne ^k   Lagarde, Arnaud ^l   Pencreach, Erwan ^e,f,m   Piard, Françoise ⁿ   Elias, Dominique ^o   Parc, Yann ^c,i   Olschwang, Sylviane ^l,p,q   Milano, Gérard ^g   Laurent Puig, Pierre ^r   Boige, Valérie ^o,r   more..

^a Cartes d'Identité des Tumeurs Program Ligue Nationale Contre le Cancer   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CANCER RESEARCH CENTER OF TOULOUSE   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f HÔPITAL DE HAUTEPIERRE   (France)

^g CENTRE ANTOINE LACASSAGNE   (France)

^h Clinique St George   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^j UNIVERSITY HOSPITAL OF NICE   (France)

^k HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^l TIMONE HOSPITAL   (France)

^m UNIVERSITY HOSPITAL OF STRASBOURG   (France)

ⁿ DIJON UNIVERSITY HOSPITAL   (France)

^o INSTITUT GUSTAVE ROUSSY   (France)

^p Hôpital Privé Clairval   (France)

^q Hospital Ambroise Pare   (France)

^r UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MESSENGER RNA; PROTEIN P53; TRANSCRIPTOME;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER STEM CELL; CHROMOSOMAL INSTABILITY; COLON CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CPG ISLAND; DOWN REGULATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; MOLECULAR BIOLOGY; MULTICENTER STUDY; ONCOGENE K RAS; PHENOTYPE; RECURRENCE FREE SURVIVAL; SURVIVAL; UPREGULATION; WNT SIGNALING PATHWAY;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CLUSTER ANALYSIS; COLONIC NEOPLASMS; FEMALE; FRANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INDIVIDUALIZED MEDICINE; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84878302099     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001453     Document Type: Article

References (39)

1. Greenlee RT, Murray T, Bolden S, Wingo PA, (2000) Cancer statistics, 2000. CA Cancer J Clin 50: 7-33.
2. American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven.
3. Popat S, Hubner R, Houlston RS, (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23: 609-618.
4. Hutchins G, Southward K, Handley K, Magill L, Beaumont C, et al. (2011) Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol 29: 1261-1270.
5. Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, et al. (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22: 1564-1571.
6. Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, et al. (2005) Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23: 3526-3535.
7. Salazar R, Roepman P, Capella G, Moreno V, Simon I, et al. (2011) Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J Clin Oncol 29: 17-24.
8. O'Connell MJ, Lavery I, Yothers G, Paik S, Clark-Langone KM, et al. (2010) Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. J Clin Oncol 28: 3937-3944.
9. Jass JR, (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130.
10. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, et al. (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 104: 18654-18659.
11. Kang GH, (2011) Four molecular subtypes of colorectal cancer and their precursor lesions. Arch Pathol Lab Med 135: 698-703.
12. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, et al. (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22: 271-282.
13. Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
14. Lièvre A, Bachet JB, Boige V, Cayre A, Le Corre D, et al. (2008) KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 26: 374-379.
15. Cabelguenne A, Blons H, de Waziers I, Carnot F, Houllier AM, et al. (2000) p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. J Clin Oncol 18: 1465-1473.
16. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257.
17. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793.
18. de Reyniès A, Assié G, Rickman DS, Tissier F, Groussin L, et al. (2009) Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 27: 1108-1115.
19. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
20. Johnson WE, Li C, Rabinovic A, (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127.
21. Guedj M, Marisa L, de Reynies A, Orsetti B, Schiappa R, et al. (2012) A refined molecular taxonomy of breast cancer. Oncogene 31: 1196-1206.
22. Monti S, Tamayo P, Mesirov J, Golub T, (2003) Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn 52: 91-118.
23. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100: 8418-8423.
24. Merlos-Suárez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, et al. (2011) The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8: 511-524.
25. Kosinski C, Li VS, Chan AS, Zhang J, Ho C, et al. (2007) Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci U S A 104: 15418-15423.
26. Popovici V, Budinska E, Tejpar S, Weinrich S, Estrella H, et al. (2012) Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J Clin Oncol 30: 1288-1295.
27. Laiho P, Kokko A, Vanharanta S, Salovaara R, Sammalkorpi H, et al. (2007) Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene 26: 312-320.
28. Snover DC, (2011) Update on the serrated pathway to colorectal carcinoma. Hum Pathol 42: 1-10.
29. Liang JJ, Bissett I, Kalady M, Bennet A, Church JM, (2012) Importance of serrated polyps in colorectal carcinogenesis. ANZ J Surg E-pub ahead of print. doi:10.1111/j.1445-2197.2012.06269.x.
30. Alfaro MP, Pagni M, Vincent A, Atkinson J, Hill MF, et al. (2008) The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci U S A 105: 18366-18371.
31. Oh SC, Park YY, Park ES, Lim JY, Kim SM, et al. (2011) Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer. Gut 61: 1291-1298.
32. Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, et al. (2007) Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clin Cancer Res 13: 498-507.
33. Salazar R, Tabernero J, Moreno V, Nitsche U, Bachleitner-Hofmann T, et al. (2012) Validation of a genomic classifier (ColoPrint) for predicting outcome in the T3-MSS subgroup of stage II colon cancer patients [abstract 3510]. American Society of Clinical Oncology Annual Meeting; 1-5 Jun 2012; Chicago, Illinois, US.
34. (2011) A prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint (PARSC). ClinicalTrials.gov: NCT00903565. Available: http://clinicaltrials.gov/ct2/show/NCT00903565. Accessed 16 April 2013.
35. Gray RG, Quirke P, Handley K, Lopatin M, Magill L, et al. (2011) Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. J Clin Oncol 29: 4611-4619.
36. Venook AP, Niedzwiecki D, Lopatin M, Lee M, Friedman PN, et al. (2011) Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581 [abstract]. 2011 ASCO Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol 29 (May 20 Suppl):: 3518.
37. O'Connell M, Lee M, Lopatin M, Yothers G, Clark-Langone K, et al. (2012) Validation of the 12-gene colon cancer recurrence score (RS) in NSABP C07 as a predictor of recurrence in stage II and III colon cancer patients treated with 5FU/LV (FU) and 5FU/LV+oxaliplatin (FU+Ox) [abstract]. 2012 ASCO Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol 30 (May 20 Suppl):: 3512.
38. Roth A, Di Narzo AF, Tejpar S, Bosman F, Popovici V, et al. (2012) Validation of two gene-expression risk scores in a large colon cancer cohort and contribution to an improved prognostic method [abstract 3509]. American Society of Clinical Oncology Annual Meeting; 1-5 Jun 2012; Chicago, Illinois, US.
39. Weiser MR, Gönen M, Chou JF, Kattan MW, Schrag D, (2011) Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol 29: 4796-4802.